Antibiotic Treatment Induces Long-lasting Changes in the Fecal Microbiota that Protect Against Colitis. Issue 10 (October 2016)
- Record Type:
- Journal Article
- Title:
- Antibiotic Treatment Induces Long-lasting Changes in the Fecal Microbiota that Protect Against Colitis. Issue 10 (October 2016)
- Main Title:
- Antibiotic Treatment Induces Long-lasting Changes in the Fecal Microbiota that Protect Against Colitis
- Authors:
- Ward, Naomi L.
Phillips, Caleb D.
Nguyen, Deanna D.
Shanmugam, Nanda Kumar N.
Song, Yan
Hodin, Richard
Shi, Hai Ning
Cherayil, Bobby J.
Goldstein, Allan M. - Abstract:
- Abstract : Background: The interplay between host genetics, immunity, and microbiota is central to the pathogenesis of inflammatory bowel disease. Previous population-based studies suggested a link between antibiotic use and increased inflammatory bowel disease risk, but the mechanisms are unknown. The purpose of this study was to determine the long-term effects of antibiotic administration on microbiota composition, innate immunity, and susceptibility to colitis, as well as the mechanism by which antibiotics alter host colitogenicity. Methods: Wild-type mice were given broad-spectrum antibiotics or no antibiotics for 2 weeks, and subsequent immunophenotyping and 16S rRNA gene sequencing–based analysis of the fecal microbiome were performed 6 weeks later. In a separate experiment, control and antibiotic-treated mice were given 7 days of dextran sulfate sodium, 6 weeks after completing antibiotic treatment, and the severity of colitis scored histologically. Fecal transfer was performed from control or antibiotic-treated mice to recipient mice whose endogenous microbiota had been cleared with antibiotics, and the susceptibility of the recipients to dextran sulfate sodium–induced colitis was analyzed. Naive CD4 + T cells were transferred from control and antibiotic-treated mice to immunodeficient Rag-1 −/− recipients and the severity of colitis compared. Results: Antibiotics led to sustained dysbiosis and changes in T-cell subpopulations, including reductions in colonic laminaAbstract : Background: The interplay between host genetics, immunity, and microbiota is central to the pathogenesis of inflammatory bowel disease. Previous population-based studies suggested a link between antibiotic use and increased inflammatory bowel disease risk, but the mechanisms are unknown. The purpose of this study was to determine the long-term effects of antibiotic administration on microbiota composition, innate immunity, and susceptibility to colitis, as well as the mechanism by which antibiotics alter host colitogenicity. Methods: Wild-type mice were given broad-spectrum antibiotics or no antibiotics for 2 weeks, and subsequent immunophenotyping and 16S rRNA gene sequencing–based analysis of the fecal microbiome were performed 6 weeks later. In a separate experiment, control and antibiotic-treated mice were given 7 days of dextran sulfate sodium, 6 weeks after completing antibiotic treatment, and the severity of colitis scored histologically. Fecal transfer was performed from control or antibiotic-treated mice to recipient mice whose endogenous microbiota had been cleared with antibiotics, and the susceptibility of the recipients to dextran sulfate sodium–induced colitis was analyzed. Naive CD4 + T cells were transferred from control and antibiotic-treated mice to immunodeficient Rag-1 −/− recipients and the severity of colitis compared. Results: Antibiotics led to sustained dysbiosis and changes in T-cell subpopulations, including reductions in colonic lamina propria total T cells and CD4 + T cells. Antibiotics conferred protection against dextran sulfate sodium colitis, and this effect was transferable by fecal transplant but not by naive T cells. Conclusions: Antibiotic exposure protects against colitis, and this effect is transferable with fecal microbiota from antibiotic-treated mice, supporting a protective effect of the microbial community. Abstract : Supplemental Digital Content Is Available in the Text.Article first published online 8 September 2016. … (more)
- Is Part Of:
- Inflammatory bowel diseases. Volume 22:Issue 10(2016:Oct.)
- Journal:
- Inflammatory bowel diseases
- Issue:
- Volume 22:Issue 10(2016:Oct.)
- Issue Display:
- Volume 22, Issue 10 (2016)
- Year:
- 2016
- Volume:
- 22
- Issue:
- 10
- Issue Sort Value:
- 2016-0022-0010-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-10
- Subjects:
- antibiotics -- colitis -- microbiome -- immunity
Inflammatory bowel diseases -- Periodicals
Colitis, Ulcerative -- Periodicals
Crohn Disease -- Periodicals
Inflammatory Bowel Diseases -- Periodicals
616.344 - Journal URLs:
- http://journals.lww.com/ibdjournal/pages/default.aspx ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1536-4844/ ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=ovft&AN=00054725-000000000-00000 ↗
https://academic.oup.com/ibdjournal ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MIB.0000000000000914 ↗
- Languages:
- English
- ISSNs:
- 1078-0998
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4478.845400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 343.xml